Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1991-02

AUTHORS

T. K. Knilans, A. Varró, P. P. Nánási, R. J. Murray, F. C. Kaiser, D. A. Lathrop

ABSTRACT

The frequency-dependent effects of FPL 13210, a new disopyramide derivative, were examined in isolated canine cardiac Purkinje fibers paced at a frequency of 2 Hz and following abrupt changes in pacing cycle length. At 2 Hz, FPL 13210 depressed Vmax while shortening action potential duration measured at 50% of repolarization (APD50) and not affecting duration measured at 90% of repolarization (APD90). These effects were concentration dependent over the range of 1–30 μM. The depression of Vmax produced by 5μM FPL 13210 was not significantly different than that produced by 18 μM disopyramide while the preparations were paced constantly at 2 Hz. At these concentrations, recovery of Vmax was slowed by both FPL 13210 and disopyramide. The slow time constant estimated for this relation after exposure to FPL 13210 was approximately 6.5 times longer than that estimated following administration of disopyramide. In addition, APD90s evoked by early premature stimuli in the presence of 5 μM FPL 13210 were longer than those produced in the absence of drug when the diastolic interval was less than 60 ms. Later extra stimuli evoked at diastolic intervals longer than 100 ms produced shorter APD90s after FPL 13210 administration. Therefore, when FPL 13210 is compared to disopyramide using concentrations selected to produce equivalent degrees of Vmax depression, FPL 13210 produced effects on APD90 that were opposite to those produced by disopyramide when the diastolic interval was longer than normal. These effects of FPL 13210 would suggest that this compound should be classified as a class Ic antiarrhythmic agent, unlike disopyramide, a class Ia antiarrhythmic agent. More... »

PAGES

139-146

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf03029809

DOI

http://dx.doi.org/10.1007/bf03029809

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1033862486

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2036332


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Action Potentials", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Alcohols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Arrhythmia Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disopyramide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dogs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Structure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Purkinje Fibers", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.24827.3b", 
          "name": [
            "Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Knilans", 
        "givenName": "T. K.", 
        "id": "sg:person.01013466265.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013466265.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.24827.3b", 
          "name": [
            "Departments of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Varr\u00f3", 
        "givenName": "A.", 
        "id": "sg:person.013060605640.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013060605640.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.24827.3b", 
          "name": [
            "Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "N\u00e1n\u00e1si", 
        "givenName": "P. P.", 
        "id": "sg:person.0724365203.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724365203.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fisons Pharmaceuticals Rochester, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.417555.7", 
          "name": [
            "Fisons Pharmaceuticals Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murray", 
        "givenName": "R. J.", 
        "id": "sg:person.01326621246.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326621246.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fisons Pharmaceuticals Rochester, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.417555.7", 
          "name": [
            "Fisons Pharmaceuticals Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaiser", 
        "givenName": "F. C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.24827.3b", 
          "name": [
            "Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA", 
            "Departments of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lathrop", 
        "givenName": "D. A.", 
        "id": "sg:person.0761162602.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761162602.86"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1991-02", 
    "datePublishedReg": "1991-02-01", 
    "description": "The frequency-dependent effects of FPL 13210, a new disopyramide derivative, were examined in isolated canine cardiac Purkinje fibers paced at a frequency of 2 Hz and following abrupt changes in pacing cycle length. At 2 Hz, FPL 13210 depressed Vmax while shortening action potential duration measured at 50% of repolarization (APD50) and not affecting duration measured at 90% of repolarization (APD90). These effects were concentration dependent over the range of 1\u201330 \u03bcM. The depression of Vmax produced by 5\u03bcM FPL 13210 was not significantly different than that produced by 18 \u03bcM disopyramide while the preparations were paced constantly at 2 Hz. At these concentrations, recovery of Vmax was slowed by both FPL 13210 and disopyramide. The slow time constant estimated for this relation after exposure to FPL 13210 was approximately 6.5 times longer than that estimated following administration of disopyramide. In addition, APD90s evoked by early premature stimuli in the presence of 5 \u03bcM FPL 13210 were longer than those produced in the absence of drug when the diastolic interval was less than 60 ms. Later extra stimuli evoked at diastolic intervals longer than 100 ms produced shorter APD90s after FPL 13210 administration. Therefore, when FPL 13210 is compared to disopyramide using concentrations selected to produce equivalent degrees of Vmax depression, FPL 13210 produced effects on APD90 that were opposite to those produced by disopyramide when the diastolic interval was longer than normal. These effects of FPL 13210 would suggest that this compound should be classified as a class Ic antiarrhythmic agent, unlike disopyramide, a class Ia antiarrhythmic agent.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf03029809", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097576", 
        "issn": [
          "0920-3206", 
          "1573-7241"
        ], 
        "name": "Cardiovascular Drugs and Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "action potential duration", 
      "diastolic interval", 
      "antiarrhythmic agents", 
      "potential duration", 
      "canine Purkinje fiber action potential duration", 
      "Purkinje fiber action potential duration", 
      "class IA antiarrhythmic agents", 
      "class IC antiarrhythmic agent", 
      "administration of disopyramide", 
      "early premature stimuli", 
      "Ic antiarrhythmic agent", 
      "canine cardiac Purkinje fibers", 
      "depression of Vmax", 
      "recovery of Vmax", 
      "cardiac Purkinje fibers", 
      "absence of drug", 
      "electrophysiologic effects", 
      "Vmax depression", 
      "premature stimuli", 
      "disopyramide", 
      "Purkinje fibers", 
      "APD90", 
      "slow time constants", 
      "cycle length", 
      "extra stimuli", 
      "repolarization", 
      "administration", 
      "equivalent degree", 
      "depression", 
      "duration", 
      "frequency-dependent effects", 
      "interval", 
      "stimuli", 
      "agents", 
      "drugs", 
      "Vmax", 
      "effect", 
      "exposure", 
      "ms", 
      "concentration", 
      "absence", 
      "Hz", 
      "recovery", 
      "changes", 
      "presence", 
      "time constants", 
      "frequency", 
      "addition", 
      "fibers", 
      "time", 
      "degree", 
      "preparation", 
      "comparison", 
      "length", 
      "compounds", 
      "relation", 
      "derivatives", 
      "range", 
      "abrupt changes", 
      "constants"
    ], 
    "name": "Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide", 
    "pagination": "139-146", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1033862486"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf03029809"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2036332"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf03029809", 
      "https://app.dimensions.ai/details/publication/pub.1033862486"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_241.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf03029809"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf03029809'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf03029809'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf03029809'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf03029809'


 

This table displays all metadata directly associated to this object as RDF triples.

204 TRIPLES      20 PREDICATES      97 URIs      89 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf03029809 schema:about N0c498261a7ba44c983993a2f413ba936
2 N1aa327e72ea54315a74bafa93b20c04a
3 N2e4e9f28a6354baaaffe13476d3f86f7
4 N6ac62f59f6194e58bfcc164ba28ac5e2
5 N70f58f0b0d3343d5bd4ad99c8de82230
6 N76c7adb00d5b434a9a5bbc5419c74902
7 N924d02c6b9844bbb869aa2c289d6fdce
8 Nc636d52ac20445a3838f957fa9bc98d0
9 Nda0ac2e0bbfb47fc92ab9e112d646bf1
10 Ndd75c55c16404623a5c5100fab117981
11 Ne16270349d7b401c8a8f845b19e5945f
12 anzsrc-for:11
13 anzsrc-for:1109
14 schema:author Ne927a12dbf5148198a1084fe531d6bde
15 schema:datePublished 1991-02
16 schema:datePublishedReg 1991-02-01
17 schema:description The frequency-dependent effects of FPL 13210, a new disopyramide derivative, were examined in isolated canine cardiac Purkinje fibers paced at a frequency of 2 Hz and following abrupt changes in pacing cycle length. At 2 Hz, FPL 13210 depressed Vmax while shortening action potential duration measured at 50% of repolarization (APD50) and not affecting duration measured at 90% of repolarization (APD90). These effects were concentration dependent over the range of 1–30 μM. The depression of Vmax produced by 5μM FPL 13210 was not significantly different than that produced by 18 μM disopyramide while the preparations were paced constantly at 2 Hz. At these concentrations, recovery of Vmax was slowed by both FPL 13210 and disopyramide. The slow time constant estimated for this relation after exposure to FPL 13210 was approximately 6.5 times longer than that estimated following administration of disopyramide. In addition, APD90s evoked by early premature stimuli in the presence of 5 μM FPL 13210 were longer than those produced in the absence of drug when the diastolic interval was less than 60 ms. Later extra stimuli evoked at diastolic intervals longer than 100 ms produced shorter APD90s after FPL 13210 administration. Therefore, when FPL 13210 is compared to disopyramide using concentrations selected to produce equivalent degrees of Vmax depression, FPL 13210 produced effects on APD90 that were opposite to those produced by disopyramide when the diastolic interval was longer than normal. These effects of FPL 13210 would suggest that this compound should be classified as a class Ic antiarrhythmic agent, unlike disopyramide, a class Ia antiarrhythmic agent.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf N21fe99d642314b16b58d6d4d5ef84af9
21 Nbcfa923494914d6e8cae138368793112
22 sg:journal.1097576
23 schema:keywords APD90
24 Hz
25 Ic antiarrhythmic agent
26 Purkinje fiber action potential duration
27 Purkinje fibers
28 Vmax
29 Vmax depression
30 abrupt changes
31 absence
32 absence of drug
33 action potential duration
34 addition
35 administration
36 administration of disopyramide
37 agents
38 antiarrhythmic agents
39 canine Purkinje fiber action potential duration
40 canine cardiac Purkinje fibers
41 cardiac Purkinje fibers
42 changes
43 class IA antiarrhythmic agents
44 class IC antiarrhythmic agent
45 comparison
46 compounds
47 concentration
48 constants
49 cycle length
50 degree
51 depression
52 depression of Vmax
53 derivatives
54 diastolic interval
55 disopyramide
56 drugs
57 duration
58 early premature stimuli
59 effect
60 electrophysiologic effects
61 equivalent degree
62 exposure
63 extra stimuli
64 fibers
65 frequency
66 frequency-dependent effects
67 interval
68 length
69 ms
70 potential duration
71 premature stimuli
72 preparation
73 presence
74 range
75 recovery
76 recovery of Vmax
77 relation
78 repolarization
79 slow time constants
80 stimuli
81 time
82 time constants
83 schema:name Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide
84 schema:pagination 139-146
85 schema:productId N2bdc02321025405f82894b1dfc8058cb
86 N411cd0c113b34c93a6eb076a8c1fb4e5
87 Nd0be6a5fcd22452eb4f02b88ff7f253d
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033862486
89 https://doi.org/10.1007/bf03029809
90 schema:sdDatePublished 2022-11-24T20:47
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N2476f37c10e1496cbce79ef9219c7b34
93 schema:url https://doi.org/10.1007/bf03029809
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N0c498261a7ba44c983993a2f413ba936 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Female
99 rdf:type schema:DefinedTerm
100 N1aa327e72ea54315a74bafa93b20c04a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Dogs
102 rdf:type schema:DefinedTerm
103 N21fe99d642314b16b58d6d4d5ef84af9 schema:issueNumber 1
104 rdf:type schema:PublicationIssue
105 N2476f37c10e1496cbce79ef9219c7b34 schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 N2bdc02321025405f82894b1dfc8058cb schema:name pubmed_id
108 schema:value 2036332
109 rdf:type schema:PropertyValue
110 N2e4e9f28a6354baaaffe13476d3f86f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name In Vitro Techniques
112 rdf:type schema:DefinedTerm
113 N37af2afa662b4483a56b05f6374f46f9 rdf:first N8eeec7c00dfb49ec81033b237fbd373b
114 rdf:rest Nb40b2d7a458d4dfdac232b4ab369d228
115 N411cd0c113b34c93a6eb076a8c1fb4e5 schema:name doi
116 schema:value 10.1007/bf03029809
117 rdf:type schema:PropertyValue
118 N6ac62f59f6194e58bfcc164ba28ac5e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Purkinje Fibers
120 rdf:type schema:DefinedTerm
121 N70f58f0b0d3343d5bd4ad99c8de82230 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Disopyramide
123 rdf:type schema:DefinedTerm
124 N76c7adb00d5b434a9a5bbc5419c74902 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Action Potentials
126 rdf:type schema:DefinedTerm
127 N8eeec7c00dfb49ec81033b237fbd373b schema:affiliation grid-institutes:grid.417555.7
128 schema:familyName Kaiser
129 schema:givenName F. C.
130 rdf:type schema:Person
131 N924d02c6b9844bbb869aa2c289d6fdce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Animals
133 rdf:type schema:DefinedTerm
134 Naa46d2b3471f4f55b9dbc0f12b388247 rdf:first sg:person.01326621246.19
135 rdf:rest N37af2afa662b4483a56b05f6374f46f9
136 Naf3f4533b8b447e9b6805edef76cef74 rdf:first sg:person.013060605640.01
137 rdf:rest Nfa94be2cccef43749c87274d9b20a43d
138 Nb40b2d7a458d4dfdac232b4ab369d228 rdf:first sg:person.0761162602.86
139 rdf:rest rdf:nil
140 Nbcfa923494914d6e8cae138368793112 schema:volumeNumber 5
141 rdf:type schema:PublicationVolume
142 Nc636d52ac20445a3838f957fa9bc98d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Amino Alcohols
144 rdf:type schema:DefinedTerm
145 Nd0be6a5fcd22452eb4f02b88ff7f253d schema:name dimensions_id
146 schema:value pub.1033862486
147 rdf:type schema:PropertyValue
148 Nda0ac2e0bbfb47fc92ab9e112d646bf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Male
150 rdf:type schema:DefinedTerm
151 Ndd75c55c16404623a5c5100fab117981 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Anti-Arrhythmia Agents
153 rdf:type schema:DefinedTerm
154 Ne16270349d7b401c8a8f845b19e5945f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Molecular Structure
156 rdf:type schema:DefinedTerm
157 Ne927a12dbf5148198a1084fe531d6bde rdf:first sg:person.01013466265.62
158 rdf:rest Naf3f4533b8b447e9b6805edef76cef74
159 Nfa94be2cccef43749c87274d9b20a43d rdf:first sg:person.0724365203.35
160 rdf:rest Naa46d2b3471f4f55b9dbc0f12b388247
161 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
162 schema:name Medical and Health Sciences
163 rdf:type schema:DefinedTerm
164 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
165 schema:name Neurosciences
166 rdf:type schema:DefinedTerm
167 sg:journal.1097576 schema:issn 0920-3206
168 1573-7241
169 schema:name Cardiovascular Drugs and Therapy
170 schema:publisher Springer Nature
171 rdf:type schema:Periodical
172 sg:person.01013466265.62 schema:affiliation grid-institutes:grid.24827.3b
173 schema:familyName Knilans
174 schema:givenName T. K.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013466265.62
176 rdf:type schema:Person
177 sg:person.013060605640.01 schema:affiliation grid-institutes:grid.24827.3b
178 schema:familyName Varró
179 schema:givenName A.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013060605640.01
181 rdf:type schema:Person
182 sg:person.01326621246.19 schema:affiliation grid-institutes:grid.417555.7
183 schema:familyName Murray
184 schema:givenName R. J.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326621246.19
186 rdf:type schema:Person
187 sg:person.0724365203.35 schema:affiliation grid-institutes:grid.24827.3b
188 schema:familyName Nánási
189 schema:givenName P. P.
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724365203.35
191 rdf:type schema:Person
192 sg:person.0761162602.86 schema:affiliation grid-institutes:grid.24827.3b
193 schema:familyName Lathrop
194 schema:givenName D. A.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761162602.86
196 rdf:type schema:Person
197 grid-institutes:grid.24827.3b schema:alternateName Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
198 Departments of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
199 schema:name Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
200 Departments of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
201 rdf:type schema:Organization
202 grid-institutes:grid.417555.7 schema:alternateName Fisons Pharmaceuticals Rochester, NY, USA
203 schema:name Fisons Pharmaceuticals Rochester, NY, USA
204 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...